COPD management in primary care: An observational, community pharmacy-based study

Annals of Pharmacotherapy

Volumn 44, Issue 2, 2010, Pages 257-266

  Mehuys, Els ^a   Boussery, Koen ^a   Adriaens, Els ^a   Van Bortel, Luc ^b   De Bolle, Leen ^a   Van Tongelen, Inge ^a   Remon, Jean Paul ^a   Brusselle, Guy ^c  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

COPD; Disease management; Pharmacotherapy; Primary care

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; THEOPHYLLINE;

ADULT; AGED; ARTICLE; BELGIUM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; COMMUNITY CARE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; HEALTH STATUS; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; METERED DOSE INHALER; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACY; PREDICTOR VARIABLE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SMOKING CESSATION;

ADMINISTRATION, INHALATION; AEROSOLS; AGED; AGED, 80 AND OVER; BELGIUM; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MEDICATION ADHERENCE; MEDICATION ERRORS; METERED DOSE INHALERS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SMOKING;

EID: 76149124200     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M481     Document Type: Article

References (24)

1. GOLD. Global Initiative for Chronic Obstructive Lung Disease. Updated 2008. www.goldcopd.com (accessed 2009 Nov 10).
2. Ramsey SD. Suboptimal medical therapy in COPD: exploring the causes and consequences. Chest 2000;117:33S-7S.
3. Bourbeau J, Sebaldt RJ, Day A, et al. Practice patterns in the management of chronic obstructive pulmonary disease in primary practice: the CAGE study. Can Respir J 2008;15:13-9.
4. Decramer M, Bartsch P, Pauwels R, Yernault JC. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch Chest Dis 2003;59:62-80.
5. Glaab T, Banik N, Rutschmann OT, Wencker M. National survey of guideline-compliant COPD management among pneumologists and primary care physicians. COPD 2006;3:141-8.
6. Rutschmann OT, Janssens JP, Vermeulen B, Sarasin FP. Knowledge of guidelines for the management of COPD: a survey of primary care physicians. Respir Med 2004;98:932-7.
7. Miravitlles M, de la Roza C, Naberan K, Lamban M, Gobartt E, Martin A. Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 2007;101:1753-60.
8. Meulepas MA, Jacobs JE, Smeenk FW, et al. Effect of an integrated primary care model on the management of middle-aged and old patients with obstructive lung diseases. Scand J Prim Health Care 2007;25:186-92.
9. Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 2004;34:608-14.
10. Chavannes NH, Grijsen M, van den Akker M, et al. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J 2009;14:crj-2008
11. Casas A, Troosters T, Garcia-Aymerich J, et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 2006; 28:123-30.
12. Mehuys E, Van Bortel L, De Bolle L, et al. Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J 2008;31:790-9.
13. Mehuys E, Van Bortel L, Annemans L, et al. Medication use and disease control of asthmatic patients in Flanders: a cross-sectional community pharmacy study. Respir Med 2006;100:1407-14.
14. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-97.
15. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health 1996;86:1805-8.
16. Christensen DB, Williams B, Goldberg HI, Martin DP, Engelberg R, LoGerfo JP. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997;35:1164-70.
17. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
18. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13.
19. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
20. Radeos MS, Camargo CA Jr. Predicted peak expiratory flow: differences across formulae in the literature. Am J Emerg Med 2004;22:516-21.
21. Belgian Health Interview Survey. www.iph.fgov.be/epidemio/hisia/index.htm (accessed 2009 Nov 10).
22. Schokkaert E, Van de Voorde C. Health care reform in Belgium. Health Econ 2005;14:S25-39.
23. Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
24. Schermer T, Heijdra Y, Zadel S, et al. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD. Respir Med 2007;101:1355-62.